Systemic Anaplastic Large Cell Lymphoma
Also known as: Systemic Anaplastic Large-Cell Lymphoma / Anaplastic large cell lymphoma, ALK-positive / Large cell anaplastic lymphoma T cell and Null cell type (disorder) / Anaplastic large-cell lymphoma / Anaplastic large cell lymphoma, T cell and Null cell type (morphologic abnormality) / Lymphoma, Large-Cell, Anaplastic
Drug | Drug Name | Drug Description |
---|---|---|
DB08870 | Brentuximab vedotin | A CD30-directed antibody-drug conjugate used to treat various types of lymphoma. |
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB08865 | Crizotinib | 1 | Completed | 1 |
DB01167 | Itraconazole | 1 | Completed | 1 |
DB01045 | Rifampicin | 1 | Completed | 1 |
DB08870 | Brentuximab vedotin | 1 / 2 | Withdrawn | 1 |
DB09063 | Ceritinib | 1 / 2 | Withdrawn | 1 |
DB08865 | Crizotinib | 4 | Withdrawn | 1 |